Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Interim Management Statement

21 Oct 2008 14:11

RNS Number : 3513G
Flying Brands Limited
21 October 2008
 



21 October 2008

Flying Brands Limited ('Flying Brands' or the 'Group')

Interim Management Statement for the three months to 26 September 2008

Flying Brands, the Jersey-based home shopping group, is today issuing an Interim Management Statement for the three months to 26 September 2008.

In the Trading Update released in September 2008, the Group explained that a series of recent adverse events had had a material impact on year-to-date trading and that management had responded with a number of actions to mitigate this shortfall in performance for the full year. These actions are progressing well and October trading is on forecast

Sales for the three months for the whole Group were £7.5(2007:£9.3m) and consistent with our expectations at the time of our recent Trading Update. Excluding the Greetings Direct business that is being closed down, sales for the three months were £5.6m being £0.9m down on those for the comparable period in 2007, around £0.3m of which is explained by timing.

The Garden Division's sales were down by £0.6m. £0.2m due to timing and the remainder due predominantly to the poor weather in August. 

The Entertainment Division's sales declined by £0.2m as a result of planned reduction in loss-making recruitment activity for Listen2 and a timing issue for Benham due to a delay by the Royal Mail in issuing their Olympics first day stamp covers.

Flying Flowers' sales were lower by £0.1m.

In terms of the financial position, net debt within the Group at 26 September was £4.8m. The Group continues to pay down this debt on schedule and to enjoy good relationship with its bank.

Tricia Killen, Chief Executivecommented:

"The mitigating actions, outlined in the recent Trading Update are progressing well and we are seeing improved response rates from our revamped promotional mailings.

From the beginning of this month, we have increased the selling price of selective Garden Bird Supplies products to offset rising ingredient costs and, in the first two weeks, our sales have been significantly higher than for the same period last year. We are confident that our projected gains from these price increases will be achieved.

This week, we are also implementing selective price increases across the Flying Flowers business to compensate for rising product costs. Our pricing remains very competitive versus others in the marketplace.

New Christmas catalogue campaigns have been developed for the significant active database of non Flying Flowers customers, who would not normally receive Christmas offers from Flying Brands and the first of these catalogues will be mailed this week."

For further information, please contact:

Flying Brands Limited 01245 228300

Patricia Killen, Chief Executive

Graham Norton, Finance Director

Smithfield Consultants 020 7360 4900

John Kiely

Notes to editors

Jersey based Flying Brands Limited (LSE: FBDU) is a multi brand home shopping group. Founded in 1981, it was admitted to the Official List of the London Stock Exchange in 1993. The Group operates the following divisions:

* Gifts (Flying Flowers, the UK's largest flowers by post brand, despatching nearly one million bouquets a year; Greetings Direct, the UK's only continuity greeting cards business)

* Garden (Gardening Direct, one of the UK's largest mail order bedding plants and gardening products operations; Garden Bird Supplies, a leading provider of food and accessories for birds and other wildlife; Sarah Raven's Kitchen and Garden for hard to find plants and household accessories)

* Entertainment (Listen2, the leading mail order audio books, DVD and video publisher and distributor; Benham, the first day cover stamps and coins collectables specialist)

More information can be found at: www.flyingbrands.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSXFLFLVBBBFBQ
Date   Source Headline
27th May 20257:00 amRNSChange of Name
22nd May 20252:23 pmRNSResult of AGM
2nd May 20257:29 amRNSApplication: FDA Breakthrough Therapy Designation
29th Apr 202510:49 amRNSNotice of AGM
25th Apr 20251:46 pmRNSPublication of Annual Report
11th Apr 20253:32 pmRNSPromising Preliminary Results of Phase 1 Study
18th Mar 202510:38 amRNSPlacing to raise £250,000
3rd Feb 20257:00 amRNSIB Expands Distribution with Blackford
22nd Jan 20257:00 amRNSOperations Update
10th Jan 20257:49 amRNSIB and Prism Secure First Installation
20th Nov 20247:00 amRNSImaging Biometrics Expands Distribution
19th Nov 202411:27 amRNSBoard Changes
5th Nov 20247:00 amRNSNew Patent Application and Trading Update
15th Oct 202410:28 amRNSHolding(s) in Company
14th Oct 202412:08 pmRNSHolding(s) in Company
14th Oct 202412:05 pmRNSPDMR dealing and TR1 announcement
11th Oct 202410:42 amRNSAcquisition of Interest by Braveheart
25th Jun 20249:59 amRNSIB Opens Expanded Access Program
14th Jun 20248:38 amRNSClinical Trial Updates
29th May 20243:08 pmRNSResult of AGM
23rd May 20247:00 amRNSMajor East Coast Health System Chooses IB Nimble
20th May 20247:10 amRNSSecond FDA Rare Pediatric Disease Designation
17th May 20247:00 amRNSIB Software Enhances Clinical Decision-Making
10th May 20248:15 amRNSRare Pediatric Disease Designation Granted to GaM
2nd May 202412:47 pmRNSIB Announces Expanded Access Program for GaM
29th Apr 20243:26 pmRNSPublication of Annual Report
5th Mar 20247:00 amRNSGrant of Options
1st Mar 20248:22 amRNSHolding(s) in Company
1st Mar 20248:20 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSResult of Broker Option and Total Voting Rights
22nd Feb 20247:00 amRNSPlacing and Broker Option
9th Feb 202412:49 pmRNSFDA Application Update
2nd Feb 20248:39 amRNSIB awarded a $100,000 grant
22nd Jan 202410:05 amRNSHolding(s) in Company
15th Jan 20247:01 amRNSDirector Dealings and Conversion of CLNs
15th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSIB Launching an Expanded Access Program for GaM
19th Dec 20232:29 pmRNSImaging Biometrics granted FDA “Fast-Track”
5th Dec 202310:58 amRNSIQ-AI Announces Positive Interim Phase 1 Results
20th Nov 20231:42 pmRNSHolding(s) in Company
9th Nov 202311:38 amRNSDirector Dealing and Conversion of CLNs
8th Nov 202310:59 amRNSApplication for Pediatric Rare Disease Designation
6th Nov 20231:02 pmRNSHolding(s) in Company
18th Oct 20232:29 pmRNSUpdate Regarding Imaging Biometrics LLC
13th Oct 20238:55 amRNSIB Letter to Shareholders
9th Oct 20237:00 amRNSOrphan Drug Status to GaM and Total Voting Rights
3rd Oct 202311:30 amRNSHolding(s) in Company
19th Sep 20232:32 pmRNSIQ-AI shares cease trading on the OTCQB
8th Sep 20237:00 amRNSReduced Gadolinium Approach Validated'
18th Aug 202312:06 pmRNSUpdate on Collaboration Agreement with Mayo Clinic

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.